denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.
Symposia: ASH-a-Palooza
Program: Trainee Activities and Services
Hematology Disease Topics & Pathways:
Research, Epidemiology, Clinical Research, Health outcomes research, Health disparities research, Diversity, Equity, and Inclusion (DEI), Patient-reported outcomes
Hematology Disease Topics & Pathways:
Research, Epidemiology, Clinical Research, Health outcomes research, Health disparities research, Diversity, Equity, and Inclusion (DEI), Patient-reported outcomes
Friday, December 6, 2024: 1:30 PM-3:50 PM
Café Sevilla Restaurant
(Gaslamp Quarter)
Panelists:
Maureen Okam Achebe, MD, MPH, Brigham and Women's Hospital, Harvard Medical School
,
Lanetta Bronté-Hall, MD, MPH, MSPH, University of Miami, Miller School of Medicine
,
Chancellor Donald, MD, Tulane University School of Medicine
,
Arturo Molina, MD, MS, FACP, Sutro Biopharma
,
Kerice A. Pinkney, MD, Joe DiMaggio Children’s Hospital
,
Deirdra R Terrell, PhD, University of Oklahoma Health Sciences Ctr
and
Yvonne A. Efebera, MD, OhioHealth
Disclosures:
Achebe: Fulcrum: Membership on an entity's Board of Directors or advisory committees; Vertex Pharmaceuticals: Membership on an entity's Board of Directors or advisory committees; Pharmacosmos: Membership on an entity's Board of Directors or advisory committees; Global Blood Therapeautics: Membership on an entity's Board of Directors or advisory committees. Terrell: Sanofi: Other: advisory board. Efebera: Oncopeptides, Sanofi, Janssen Oncology, Pfizer: Consultancy; Takeda, Janssen, Akcea Therapeutics, Alnylum: Speakers Bureau; Takeda, Oncopeptides, Alnylam, Sanofi, GlaxoSmithKline, ORCA Therapeutics, Bristol Myers Squibb/Celgene, Pharmacyclics through Alliance and AFT: Research Funding.
Trainees have the opportunity to meet with leaders in the field. Trainees sign up for a one-on-one Blood Buddy ten-minute mentoring session with a faculty member. Blood Buddies are experts in various hematology topic areas. This is an excellent opportunity for trainees to network with and receive mentorship from seasoned faculty. There are 3 Blood Buddies sessions at the event. Although the speakers roles are marked as primary and alternate, multiple speakers may be asked to present on the same topic if that topic will be repeated in the following sets of Blood Buddies. The featured topics are: Adult Clinical Malignant Hematology; Pediatric Clinical Malignant Hematology; Adult Clinical Classical Hematology; Pediatric Clinical Classical Hematology; BMT Pediatric and Adult; Quality Improvement; Medical Education; PhD/Laboratory; Diversity, Equity, and Inclusion; International Medical Graduates; Future of Hematology (Artificial Intelligence); Industry Career Pathway; Federal Career Pathway.